drugset
drugset / Trial / NCT00003544

Irinotecan in Treating Patients With Metastatic Colorectal Cancer

NCT00003544 ↗

Phase 2 Completed Memorial Sloan Kettering Cancer Center National Cancer Institute (NCI) · collab
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of irinotecan in treating patients with metastatic colorectal cancer.

Timeline

Start
1998-06
Primary completion
2001-03
Completion
2001-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Irinotecan Small molecule — Intravenous

Indications

colorectal cancer